Anti-muscarinic drugs increase rectal compliance and exacerbate constipation in chronic spinal cord injury : Anti-muscarinic drug effect on neurogenic bowel

Spinal Cord. 2019 Aug;57(8):662-668. doi: 10.1038/s41393-019-0263-7. Epub 2019 Feb 25.

Abstract

Study design: Prospective cohort study OBJECTIVES: We hypothesized that anti-muscarinic agents alter rectal compliance in SCI patients and that altered rectal compliance relates to bowel symptomatology. Our primary aim was to compare rectal compliance before and after the institution of anti-muscarinics (solifenacin and tolterodine) and an adrenoceptor agonist (mirabegron) in these patients. Additionally, we wanted to evaluate if anorectal manometry differed before and after use of anti-muscarinic agents.

Setting: Tertiary neurogastroenterology clinic, London METHODS: Thirty-five patients with supraconal spinal cord injury (SCI) underwent anal manometry, assessment of rectoanal inhibitory reflex (RAIR) and rectal compliance before and after anti-muscarinic treatment (for overactive bladder) was started (mean follow-up 12 weeks). Patients were assessed identically, pre-and post-treatment (solifenacin n = 17, tolterodine n = 10, mirabegron n = 8). Doses used were as for non-SCI patients.

Results: Resting, squeeze and cough pressures were unchanged after anti-muscarinic treatment. Rectal compliance was significantly raised after anti-muscarinic treatment (p = 0.001). The percent amplitude of maximal sphincter relaxation of the RAIR was decreased (p < 0.001) and excitation latency was increased (p = 0.006). There was no significant change in the duration of recovery of the RAIR. There was a significant increase of the Wexner Constipation Score (p = 0.001) but no change in the Wexner Incontinence Score. There was a significant correlation between change in rectal compliance and change in Wexner Constipation Score (p = 0.001). Thus, increasing compliance of the rectum is associated with worsening of constipation after anti-muscarinic therapy. However, there were no changes in anorectal manometry or rectal compliance in those who received mirabegron.

Conclusion: Anti-muscarinic therapy for overactive bladder increases compliance of the neurogenic rectum and alters anorectal reflex activity, with worsening of constipation.

MeSH terms

  • Adult
  • Aged
  • Anal Canal / drug effects
  • Anal Canal / physiology
  • Cohort Studies
  • Constipation / chemically induced*
  • Constipation / diagnosis
  • Constipation / etiology
  • Female
  • Humans
  • Male
  • Manometry / methods
  • Middle Aged
  • Muscarinic Antagonists / adverse effects*
  • Neurogenic Bowel / chemically induced*
  • Neurogenic Bowel / diagnosis
  • Neurogenic Bowel / etiology
  • Prospective Studies
  • Rectum / drug effects*
  • Rectum / physiology
  • Reflex / physiology
  • Spinal Cord Injuries / complications
  • Spinal Cord Injuries / diagnosis
  • Spinal Cord Injuries / drug therapy*
  • Treatment Outcome
  • Young Adult

Substances

  • Muscarinic Antagonists